 | Newron Announces Half-Year 2021 Results
finance.yahoo.com - September 16 at 9:33 AM |
 | Short Interest in Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Decreases By 98.7%
americanbankingnews.com - September 14 at 4:56 PM |
| Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)
finance.yahoo.com - September 6 at 5:01 PM |
| Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Short Interest Up 7,600.0% in August
americanbankingnews.com - August 26 at 2:11 PM |
 | Newron announces Paragraph IV ANDA filings for Xadago® (safinamide) in the USA
uk.finance.yahoo.com - May 20 at 2:06 AM |
 | BRIEF-Supernus Pharmaceuticals Says Co, Newron Received Notice Letters From MSN, Optimus & Zenara
msn.com - May 19 at 8:58 PM |
| Newron Announces Paragraph IV ANDA Filing for Xadago® (safinamide) in the USA
finance.yahoo.com - May 4 at 9:50 AM |
 | DGAP-News: Newron announces results of explanatory studies with evenamide in healthy volunteers and patients with schizophrenia
marketwatch.com - April 2 at 8:05 AM |
|
| Newron Pharmaceuticals S.p.A. (NWPHF)
ca.finance.yahoo.com - March 28 at 6:03 PM |
 | Newron Pharmaceuticals S.p.A.: Newron announces 2020 financial results and provides outlook for 2021
finanznachrichten.de - March 16 at 10:10 AM |
| DGAP-News: Newron announces 2020 financial results and provides outlook for 2021
marketwatch.com - March 16 at 10:10 AM |
| Newron Announces 2020 Financial Results and Provides Outlook For 2021
finance.yahoo.com - March 16 at 10:10 AM |
| DGAP-News: Newron and Zambon sign agreement for potentially pivotal study with safinamide in Parkinson's disease patients
marketwatch.com - March 15 at 8:52 AM |
| Newron and Zambon Sign Agreement for Potentially Pivotal Study with safinamide in Parkinson’s Disease Patients
finance.yahoo.com - March 15 at 8:52 AM |
| Newron Signs Agreement for Starting a Potentially Pivotal Study With Safinamide in Parkinson’s Disease Patients
finance.yahoo.com - March 15 at 8:52 AM |
| DGAP-News: Newron completes enrollment of explanatory safety and efficacy study with evenamide in schizophrenia patients
marketwatch.com - January 22 at 9:12 AM |
| Newron Completes Enrollment of Explanatory Safety and Efficacy Study With Evenamide in Schizophrenia Patients
finance.yahoo.com - January 21 at 8:42 AM |
| Newron Announces Half-Year 2020 Results
finance.yahoo.com - September 15 at 8:57 AM |
 | Newron Pharmaceuticals Provides Clinical and Business Update
businesswire.com - August 11 at 10:04 PM |
 | Newron Pharmaceuticals issues clinical update
seekingalpha.com - August 11 at 5:04 PM |
| Newron Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 29 at 6:28 PM |
| Newron Reports Top-Line Results From Its STARS Study Evaluating Sarizotan in Patients With Rett Syndrome
finance.yahoo.com - May 4 at 6:25 PM |
| Newron Receives Third Tranche from Financing Agreement with European Investment Bank (EIB)
finance.yahoo.com - April 15 at 12:56 PM |
| Newron to report results from key sarizotan study next quarter
seekingalpha.com - March 11 at 2:42 PM |
| Newron Updates On STARS Study FDA Interaction
finance.yahoo.com - March 11 at 8:03 AM |
 | BRIEF-Newron Pharmaceuticals FY Net Loss Widens To EUR 20.2 Million
uk.reuters.com - March 5 at 10:20 AM |
|
| Newron Announces 2019 Financial Results and Provides Outlook For 2020
finance.yahoo.com - March 5 at 10:20 AM |
| Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York
finance.yahoo.com - February 4 at 8:18 AM |
 | Newron Pharmaceuticals focusing on treating Rett syndrome with drug acquired from Merck
www.proactiveinvestors.com - January 14 at 10:24 PM |
| Newron Announces Initiation of New Clinical Trial With Evenamide in Patients With Schizophrenia, Following Approval of Plan By FDA
www.businesswire.com - January 9 at 4:24 PM |
| BRIEF-Newron Receives FDA Rare Pediatric Disease Designation For Sarizotan
uk.reuters.com - November 19 at 2:26 PM |
| Newron nabs RPD tag in U.S. for sarizotan for Rett syndrome
seekingalpha.com - November 19 at 9:25 AM |
| Those Who Purchased Newron Pharmaceuticals (VTX:NWRN) Shares Three Years Ago Have A 70% Loss To Show For It
finance.yahoo.com - November 18 at 1:23 PM |
| Newron's safinamide OK'd in Japan for Parkinson's
seekingalpha.com - September 21 at 1:09 AM |
| Newron Pharma updates on regulatory status of evenamide for schizophrenia
seekingalpha.com - May 28 at 10:34 AM |
